TORONTO DOMINION BANK - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 560 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2015. The put-call ratio across all filers is 2.18 and the average weighting 1.4%.

Quarter-by-quarter ownership
TORONTO DOMINION BANK ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$35,061,000
+108.1%
1,511,400
+42.6%
0.07%
+86.8%
Q1 2018$16,847,000
-86.9%
1,059,626
-82.7%
0.04%
-90.0%
Q4 2017$128,125,000
+113.8%
6,127,801
+46.5%
0.38%
+96.9%
Q3 2017$59,933,000
-77.4%
4,182,890
-72.6%
0.19%
-77.2%
Q2 2017$265,145,000
+99.5%
15,255,696
+26.8%
0.85%
+138.9%
Q1 2017$132,931,000
+20.7%
12,034,997
+58.5%
0.36%
+8.9%
Q4 2016$110,101,000
-58.2%
7,593,122
-29.2%
0.33%
-62.7%
Q3 2016$263,187,000
+35.5%
10,724,557
+11.4%
0.87%
+8.2%
Q2 2016$194,180,000
-24.4%
9,628,635
-1.7%
0.81%
-49.1%
Q1 2016$256,763,000
-50.6%
9,793,107
+90.3%
1.59%
-49.9%
Q4 2015$519,505,000
-45.4%
5,147,372
-3.4%
3.16%
-41.6%
Q3 2015$950,936,000
-2.4%
5,327,569
+21.4%
5.42%
+17.9%
Q2 2015$974,604,000
+38.0%
4,387,042
+22.7%
4.60%
+51.2%
Q1 2015$706,415,000
+33.9%
3,575,969
-2.8%
3.04%
+45.5%
Q4 2014$527,660,000
-26.5%
3,680,264
-32.9%
2.09%
-16.8%
Q3 2014$717,916,000
-21.1%
5,482,276
-23.8%
2.51%
-15.2%
Q2 2014$909,480,000
-12.8%
7,191,461
-9.3%
2.96%
-18.7%
Q1 2014$1,042,620,000
+2.1%
7,924,851
-9.1%
3.64%
+3.9%
Q4 2013$1,021,281,000
+24.6%
8,716,365
+10.9%
3.51%
+21.9%
Q3 2013$819,587,000
+41.7%
7,863,030
+17.2%
2.88%
+32.3%
Q2 2013$578,415,000
+121.9%
6,710,345
+93.2%
2.18%
+125.9%
Q1 2013$260,708,0003,473,9380.96%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q1 2015
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,106,379$55,398,00031.67%
Claren Road Asset Management, LLC 80,000$2,820,00024.27%
Okumus Fund Management Ltd. 3,722,464$97,901,00015.82%
Wingspan Investment Management, LP 852,900$22,431,00012.66%
FARLEY CAPITAL L.P. 307,458$8,086,00011.46%
Chou Associates Management 976,843$25,725,0008.35%
Wingspan Investment Management, LP 550,700$14,483,0008.17%
HAP Trading, LLC 4,043,900$109,610,0008.00%
LeVasseur Capital Partners LLC 128,269$3,373,0006.97%
Pershing Square Capital Management 21,591,122$567,847,0006.41%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders